Two-thirds of OECD countries encourage generics, Financial Express May 9 2017
Is the Indian patent regime weak? The Financial Express, March 4, 2014
Column: FDI in Pharma – Poor Prescription, The Financial Express, July 23, 2013
Column: What purpose does it really serve? Financial Express, May 25, 2013
Less Attention Towards Healthcare Sector, Express Pharma, February 28, 2013
Give Profit-linked sops to Contract Manufacturers, DNA, February 5, 2013
The Low-cost Argument, Businessworld, February 2, 2013
Empowered Patients’: A changing dynamic, Express Pharma, January 10, 2013
Why Tomorrow Seems Brighter Than Today?, Modern Pharma, December 2012
No Fizz in this Fiscal, Express Pharma, April 1-15, 2012
GST: Light at the end of the tunnel? Express Pharma, March 1 – 15, 2012
Pharma: High demand for skilled manpower in the industry , Shine.com, January 6, 2012
Help in the hour of need, Express Pharma, November 16-30, 2011
Setting New Standards, Express Pharma, November 1-15, 2011
Should FDI in pharma be restricted?Financial Express, October 7, 2011
India: Good Endings, Good Beginnings! Pharmaceutical Executive, September 2011
Under the CCI scanner,
Express Pharma, August 1-15, 2011
Not so Friendly Budget 2011
Express Pharma, March 15-31, 2011
Interview
Focus Reports, March 2011
Is it a ‘no budge’ Budget? Modern Pharmaceuticals, March 2011
Roundtable, India – China FTA,
Modern Pharmaceuticals, February 2011
The Question Of Brand Premium,
Businessworld, January10, 2011
The Buyout Bogey, India Today, January 9, 2011
Understand the trend or ‘perish’,
Biospectrum, January 4, 2011
Industry wants R&D incentives,
Biospectrum, January 4, 2011
Flash Back 2010, Ready to move ahead!
Express Pharma, December 16-31, 2010
Master of Innovation, Biospectrum, December 9, 2010
India keen to implement uniform marketing code for companies
Scrip, December 3, 2010
Failure to provide DP would lead to ‘unfair commercial use’
Express Pharma, 1-15 September 2010
Roundtable on Pharma census in India -A step forward for better governance?
July 2010, Modern Pharmaceuticals
DEBATE: Will acquisitions of Indian pharma companies benefit or harm Indian patients?
Express Pharma, 1-15 July 2010
Roundtable, Need for a Modified approach
Modern Pharmaceuticals, June 2010
Doctors under the influence?
Express Pharma, 16-31 May 2010
Ready to move ahead!
Express Pharma, 16-30 April, 2010
Roundtable, Modern Pharmaceuticals, Drug Research in India – Opportunities abound, February 2010
The social media super market: Pharma still plays safe
Express Pharma, 16-28 February, 2010
Focus on access, not just affordability
Express Pharma, 16-31 January 2010
Indian pharma SMEs – In the centre stage
Modern Pharmaceuticals January 2010
Green signal or traffic stopper?
Modern Pharmaceuticals, November 2009
India Fights Back, Roundtable
Modern Pharmaceuticals Sept. 2009
PCT reforms at WIPO will benefit Indian innovators, exporters
Pharmabiz, October 05, 2009
Cold chain initiatives on the anvil
Express Pharma, 1-15 August 2009
Foreword – Taking Wings
OPPI – E&Y Publication, 8 August 2009
Association Special
Biospectrum Asia, July 31, 2009
Looking beyond challenges
Express Pharma, 1-15 August 2009
Made in India or discovered in India?
Express Pharma, 16-31 July 2009
Weighing the verdict
Express Pharma, 16-31 July 2009
Modern Pharmaceuticals Roundtable
July 2009
How real is the threat of counterfeit medicines?
The Economic Times, 21 July, 2009
Nurturing Industry Needs
June 16-30, 2009, Express Pharma
Modern Pharmaceuticals Roundtable
May 2009
Ready for round 2?
May 16-31, 2009, Express Pharma
Protect or Perish
Business Today, March 5, 2009
Pharma families of India -Towards a new dawn
Express Pharma, 16-31 January 2009
Cementing the gap
Express Pharma, 1-15 December 2008
BioSpectrum November 2008 (432Kb)
November 2008
What’s ailing healthcare in India?
The Hindu Business Line, Friday, Aug 22, 2008
A tug of war
Express Pharma, 16-31 May, 2008
Towards better medicines: Need for incentives to innovate
The Economic Times, 27 Nov 2007